Aug 24, 2026
1:8
For every 8 shares held, investors received 1. The price per share adjusted from $0.28 to $2.24.
The split itself did not change the total investment value.
Skye Bioscience, Inc. (NASDAQ:SKYE) operates in the Pharmaceuticals: major industry.
Skye Bioscience, Inc. company overviewSkye Bioscience, Inc.'s most recent stock split was on August 24, 2026. It was a 1-for-8 reverse split, so shareholders received 1 share for every 8 they held.
Skye Bioscience, Inc. (NASDAQ:SKYE) has split its stock 3 times: a 59-for-25 split on October 29, 2014, a 1-for-250 reverse split on September 8, 2023, and a 1-for-8 reverse split on August 24, 2026.
Skye Bioscience, Inc. has split its stock 3 times. This history records 3 splits between October 29, 2014 and August 24, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Skye Bioscience, Inc.'s 1-for-8 reverse split on August 24, 2026, every 8 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Skye Bioscience, Inc. has not announced a new split in our records. Its most recent split was on August 24, 2026, less than a year ago. Companies announce splits in advance, and any new NASDAQ:SKYE split will appear on this page.